US National Economic Council Director Kevin Hassett played down concerns of Chinese pharmaceutical retaliation over new tariffs. He cited global pharmaceutical availability and US efforts to boost domestic production. Hassett's comments aimed to reassure against immediate alarm concerning pharmaceutical supplies.
